- Home
- BALY vs ARVN Comparison
BALY vs ARVN Comparison
Compare BALY & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BALY | ARVN |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | 10000 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.8M | 781.0M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BALY | ARVN |
|---|---|---|
| Price | $12.59 | $12.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 21 |
| Target Price | $15.40 | ★ $15.71 |
| AVG Volume (30 Days) | 87.4K | ★ 734.1K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.84 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,450,478,000.00 | $262,600,000.00 |
| Revenue This Year | $6.47 | N/A |
| Revenue Next Year | $6.48 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.06 | N/A |
| 52 Week Low | $8.46 | $5.90 |
| 52 Week High | $20.74 | $14.22 |
Technical Indicators
Market Signals| Indicator | BALY | ARVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 40.19 |
| Support Level | $11.83 | $11.07 |
| Resistance Level | $14.88 | $12.62 |
| Average True Range (ATR) | 0.98 | 0.79 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 12.50 | 35.94 |
Price Performance
Historical ComparisonAbout BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.